SCHEMBL3659513

SCHEMBL3659513

OB(O)c1c(Br)cccc1-c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
MAPK1 P28482 3/20 0.56
HSD17B10 Q99714 2/20 0.40
HPGD P15428 1/20 0.40
BCL2L1 Q07817 1/20 0.40
MGLL Q99685 2/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
BACE1 P56817 1/20 0.37
CRHBP P24387 1/20 0.36
CRHR2 Q13324 1/20 0.36
PDCD1 Q15116 1/20 0.36
CD274 Q9NZQ7 1/20 0.36
HNF4A P41235 1/20 0.36
TP53 P04637 1/20 0.36
MAPT P10636 1/20 0.36
NFKB1 P19838 1/20 0.36
RAB9A P51151 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2844082 0.85 ALDH1A1 (0.48) ALDH1A1MAPK1HSD17B10HPGDBCL2L1
SCHEMBL910660 0.81 ALDH1A1 (0.44) ALDH1A1MAPK1HSD17B10HPGDBCL2L1
SCHEMBL16050137 0.78 CA1 (0.38) ALDH1A1MAPK1MGLLCA1CA2
SCHEMBL31481988 0.78 CYP2A6 (0.58) ALDH1A1MAPK1HSD17B10HPGDBCL2L1
SCHEMBL18518065 0.77 CRHBP (0.52) ALDH1A1MAPK1HSD17B10HPGDBCL2L1
SCHEMBL30255125 0.76 PDCD1 (0.44) ALDH1A1HSD17B10HPGDBCL2L1MGLL
SCHEMBL29918585 0.76 ALDH1A1 (0.40) ALDH1A1MAPK1HSD17B10HPGDBCL2L1
SCHEMBL30451936 0.73 ALDH1A1 (1.00) ALDH1A1MAPK1HSD17B10HPGDBCL2L1
SCHEMBL115115 0.73 ALDH1A1 (1.00) ALDH1A1MAPK1HSD17B10HPGDBCL2L1
SCHEMBL2936934 0.72 ALDH1A1 (0.62) ALDH1A1MAPK1HSD17B10HPGDBCL2L1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110452237-B Thermally induced delayed fluorescent material and preparation method and application thereof 武汉尚赛光电科技有限公司 2021-02-09 CN disclosed
US-20110054229-A1 LUMINESCENT COMPOUNDS AND ELECTROLUMINESCENT DEVICE USING THE SAME GRACEL DISPLAY INC. (KR) 2011-03-03 US disclosed
EP-2215185-A1 LUMINESCENT COMPOUNDS AND ELECTROLUMINESCENT DEVICE USING THE SAME Gracel Display Inc. (KR) 2010-08-11 EP disclosed
WO-2009066815-A1 LUMINESCENT COMPOUNDS AND ELECTROLUMINESCENT DEVICE USING THE SAME GRACEL DISPLAY INC. (KR) 2009-05-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110054229-A1 LUMINESCENT COMPOUNDS AND ELECTROLUMINESCENT DEVICE USING THE SAME OCIAD2, OCIAD1, ORMDL3 ALDH1A1 574/4885MAPK1 3026/4885HSD17B10 1676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.